Romano Brothers AND Company trimmed its holdings in MetLife, Inc. (NYSE:MET – Free Report) by 1.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 53,984 shares of the financial services provider’s stock after selling 530 shares during the quarter. Romano Brothers AND Company’s holdings in MetLife were worth $4,420,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Zurich Insurance Group Ltd FI bought a new position in shares of MetLife in the third quarter worth about $91,771,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its position in MetLife by 79.1% in the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,726,209 shares of the financial services provider’s stock worth $142,378,000 after purchasing an additional 762,291 shares during the last quarter. Jacobs Levy Equity Management Inc. lifted its holdings in MetLife by 256.6% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 948,223 shares of the financial services provider’s stock worth $78,209,000 after buying an additional 682,333 shares in the last quarter. Nordea Investment Management AB boosted its position in MetLife by 16.8% in the 4th quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock valued at $347,735,000 after buying an additional 608,224 shares during the last quarter. Finally, Public Sector Pension Investment Board increased its stake in shares of MetLife by 347.4% in the 2nd quarter. Public Sector Pension Investment Board now owns 432,887 shares of the financial services provider’s stock valued at $30,384,000 after buying an additional 336,127 shares during the period. Institutional investors and hedge funds own 94.99% of the company’s stock.
MetLife Stock Performance
MET stock opened at $86.83 on Friday. MetLife, Inc. has a 1-year low of $64.61 and a 1-year high of $89.05. The business’s 50-day moving average price is $83.41 and its two-hundred day moving average price is $79.41. The firm has a market cap of $60.12 billion, a PE ratio of 17.51, a P/E/G ratio of 0.59 and a beta of 1.07. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51.
MetLife Dividend Announcement
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on the company. Jefferies Financial Group upped their price target on MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research note on Friday, September 27th. JPMorgan Chase & Co. raised their target price on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Wells Fargo & Company lowered their price target on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a research report on Tuesday, January 14th. StockNews.com lowered shares of MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Finally, Piper Sandler lifted their target price on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $89.92.
Get Our Latest Research Report on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- ETF Screener: Uses and Step-by-Step Guide
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- Breakout Stocks: What They Are and How to Identify Them
- Oilfield Leader SLB: An AI Name You Need to Know
- CD Calculator: Certificate of Deposit Calculator
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.